Hepatitis C screening for people who inject drugs in Armenia
Part of Digestive system, Infections clinical trials.
This study is testing a screening program for hepatitis C among people who inject drugs in Armenia, Colombia. It aims to find and help those who may have the virus but don't know it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have injected drugs (like heroin, cocaine, or other psychoactive substances) in the last 6 months.
- You have lived in Armenia, Colombia, or its metropolitan area for the last 6 months.
- You have a coupon inviting you to join the study.
- You are a Colombian citizen or a Venezuelan migrant.
- You are able to answer a survey on your own (not too intoxicated or limited).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers free hepatitis C testing to adults in Colombian hospitals, especially those with risk factors like past medical or dental procedures, tattoos, drug use, or certain health conditions. If you test positive, the team will help connect you to treatment.
This trial offers free hepatitis C testing for people who inject or have injected drugs. The goal is to find hidden cases early so they can get treatment.
This study looks at a step-by-step process to screen for hepatitis C, treat it, and help people clear the virus. If you meet the basic requirements, joining could help ensure you get evaluated and, if eligible, treated in a structured way.
This study tests a simple treatment for Hepatitis C in people experiencing unsheltered homelessness. It aims to help those who are receiving street medicine care and have not been treated before.
This study offers free hepatitis C testing to adults who may have risk factors for the virus. It aims to find undiagnosed cases in five cities on Colombia's Caribbean coast so people can get treatment if needed.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
Hear when a new Hepatitis C Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.